(Q39840358)

15 September 2017

1 reference

title

Natural killer cells in relation to disease and treatment (English)

1 reference

15 September 2017

Bente Klarlund Pedersen

series ordinal

1

1 reference

PubMed ID

3911816

15 September 2017

language of work or name

1 reference

1 November 1985

1 reference

15 September 2017

1 reference

15 September 2017

40

1 reference

15 September 2017

547-557

1 reference

15 September 2017

8

1 reference

Natural killer (NK) activity in the spleen of patients with Hodgkin's disease and controls

15 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Low natural-killer-cell activity in familial melanoma patients and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Heterogeneity of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Natural killer cells in resistance to virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Depressed spontaneous natural killing and interferon augmentation in patients with malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1985.TB00881.X

10.1111/J.1398-9995.1985.TB00881.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

3911816